We are live on ! Find out more
CALC icon

CalciMedica

31 hedge funds and large institutions have $24.2M invested in CalciMedica in 2025 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more capital invested

Capital invested by funds: $10.9M → $24.2M (+$13.3M)

17% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 6

0% more funds holding

Funds holding: 3131 (0)

0% less ownership

Funds ownership: 5.11%5.11% (-0%)

38% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 8

Holders
31
Holders Change
Holders Change %
0%
% of All Funds
0.37%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
7
Increased
5
Reduced
8
Closed
6
Calls
Puts
Net Calls
Net Calls Change

CALC Hedge Fund Activity: Q4 2025 in Review

31 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q4 2025, worth a combined $24.2M — up 121% from $10.9M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new CALC positions and 6 closed out — a net gain of 1 holder — while 5 added to existing stakes and 8 trimmed.

The largest buyer was Boothbay Fund Management, opening a new position worth an estimated $300K. The largest seller was Millennium Management, cutting an estimated $76.2K.

  • 31 institutional investors held CalciMedica (CALC) as of Q4 2025, unchanged from Q3 2025.
  • Funds reported $24.2M of CalciMedica stock for Q4 2025, up 121% quarter-over-quarter.
  • 7 funds opened new CalciMedica positions in Q4 2025 and 6 closed out, a net change of +1 holder.
  • The largest CalciMedica buyer in Q4 2025 was Boothbay Fund Management, an estimated $300K added.
  • The largest CalciMedica seller in Q4 2025 was Millennium Management, an estimated $76.2K sold.

Based on aggregated 13F filings for Q4 2025.